Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. DELTYBA (delamanide)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

DELTYBA (delamanide)

Medicine - Posted on May 17 2022
Active substance (DCI)
  • delamanide
history (4)
  • 4/20/22

    DELTYBA (delamanide) - Tuberculose pulmonaire multirésistante (TB-MR)

    Mise à disposition d’une nouvelle présentation. Avis favorable au remboursement dans l’extension d’indication au traitement ...
    CAV :
    54321
    icône flèche
  • 5/19/21

    DELTYBA (délamanid)

    Key points Favourable opinion for reimbursement in the indication extension to “treatment of pulmonary multi-drug resistant ...
    CAV :
    54321
    icône flèche
  • 11/6/19

    DELTYBA (delamanide)

    Réévaluation L’essentiel Avis favorable au maintien du remboursement dans le traitement de la tuberculose pulmonaire multiré...
    CAV :
    54321
    icône flèche
  • 1/20/16

    DELTYBA (delamanid), antituberculosis agent

    Moderate improvement in combination with other antituberculosis agents in the treatment of multidrug-resistant pulmonary tub...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • J04AK06
Manufacturer
OTSUKA PHARMACEUTICAL FRANCE SAS
Presentation

DELTYBA 25 mg, comprimé dispersible
B/ 48 comprimés – plaquette (alu/alu) - (Code CIP : 34009 302 421 8 6)

DELTYBA 50 mg, comprimé pelliculé
B/ 48 comprimés – plaquette thermoformée (alu/alu) - (Code CIP : 34009 300 105 7 0)

All our publications
    Bacterial infections Drug therapy Paediatrics Pulmonary and pleural diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNq1mF1v2jAUhu/5FVHuSYDS0k6BamPthrRqjBZt2k1lkkMxM3Z6bPOxXz+HUC2dHHU19RXCdo5Pznn9+FWSy+2KBWtASQXvh+2oFQbAU5FR/tAPp3fXzfPwctBIlmRNKst6UStqd8IgZUTKfljMRjMgXEY/br58BPM8YDhoBImYLSFVz9ZpRVn0mcjFDcmLNUGyFjQLVqAWIuuHuVb70SCRCk0Wg43AXzInKSTxYaQ6u7zvVseTuAj2H1G1BPxC+IM1KHCnmKlGBK6GRMGDwF1NvidOsamcgBQaUxgTtRijWNMMMusWc8IkOG0y32S3gGsGqtjEGjxepivpFJwsyXYCjyN70u/N7FBtVbPVbPe6Z73eyXnnonPhViyslMreBfMScZ5jdt+5OO92uq0YeJwBU7sZaZpfsiLc1NexU2OBijBPPaJy+FxmnvZBeHxRCxmVOSO7aClz11IRJGYa0MDA34sUb3CHBk/M1Oyf+FwzFr8y6+kBHp4yLtg0FJqrGoZcT1wLMRRcwba+o27YU9uDFinItwv7W3A78sd6xmjqCjiDIA1STSejer75Q8MHImGK/tjwnfJMbOTbM6faY0/Z53tsWoOadrSLfpy1T0+dj9RPI6ia2+dKo8ghNjSi8hjIjPhcHIsXo1F7qCeFehLn3hGJlDCo8URNR+4YVT5ZOG+693emyglr0E9Xd65i+aYBd7f7v9bQNOtX2+zGZR+wN+qszf31Wi+PvBfDrNGOkoVSuXwXx5vNJloQ2ZTEVCmao2fwV25ef+bdy/Ve2p0Snp5Sn5W34uv65Xr0XjIAx5raw/MH82zdQ6GGI3pRUtobS0dXb4/nv47WW9rjZyzxt83efRJFBfflg/TMboKOvRBMa/k1GkZ8nc9pzfeUWmkmcfktZ9BI4uI7zqDxB+vI/VI=
HYBE5Uc9wdkh7ptQ